Back
Neurocrine Biosciences Vs. Lantheus Holdings Industry Stock Comparison
Buy
57
NBIX
Neurocrine Biosciences
Last Price:
123.96
Seasonality Move:
16.93%
Sell
19
LNTH
Lantheus Holdings
Last Price:
88.35
Seasonality Move:
-1.72%
Buy
57
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy, Sell or Hold?
- The current Neurocrine Biosciences [NBIX] share price is $123.98. The Score for NBIX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- NBIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Lantheus Holdings (LNTH)
is a Sell
Is Lantheus Holdings a Buy, Sell or Hold?
- The current Lantheus Holdings [LNTH] share price is $88.32. The Score for LNTH is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- LNTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NBIX Stock Price Chart
What is Neurocrine Biosciences's stock price today?
-
The Neurocrine Biosciences share price today is $123.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
LNTH Stock Price Chart
What is Lantheus Holdings's stock price today?
-
The Lantheus Holdings share price today is $88.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing selling pressure, which indicates risk of future bearish movement.
NBIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.15 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | -510791 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
LNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.06 | Sell |
| Relative Strength Index (14 RSI): | 27.58 | Sell |
| Chaikin Money Flow: | -2889023 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.73 - 115.15) | Sell |
| Bollinger Bands (100): | (91.31 - 114.87) | Sell |
NBIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.78 | Buy |
| 20-day SMA: | 118.43 | Buy |
| 50-day SMA: | 118.58 | Buy |
| 200-day SMA: | 134.42 | Sell |
| 8-day EMA: | 121.79 | Buy |
| 20-day EMA: | 119.61 | Buy |
| 50-day EMA: | 122.06 | Buy |
| 200-day EMA: | 128.44 | Sell |
LNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.9 | Sell |
| 20-day SMA: | 109.25 | Sell |
| 50-day SMA: | 107.57 | Sell |
| 200-day SMA: | 84.57 | Buy |
| 8-day EMA: | 103.08 | Sell |
| 20-day EMA: | 106.94 | Sell |
| 50-day EMA: | 106.44 | Sell |
| 200-day EMA: | 91.42 | Sell |
Neurocrine Biosciences Earnings Growth & NBIX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.45 per share, and an increase next year of $1.13 per share.
Lantheus Holdings Earnings Growth & LNTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.30 per share.
Neurocrine Biosciences Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lantheus Holdings Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||